Inhibitor Therapeutics INTI
OTC INTI
$0.10 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Total Liabilities (2012 - 2026)

Updated

Inhibitor Therapeutics (INTI) reported Total Liabilities of $3.2 million for Q2 2026, up 0.1% from $3.19 million a year earlier but down 6.3% from the prior quarter.

Analysis

Inhibitor Therapeutics (INTI) Total Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, Inhibitor Therapeutics posted Total Liabilities of $3.8 million, up 2.5% from FY2024.

  • Total Liabilities has a five-year compound annual growth rate of 1.7% (FY2020 to FY2025).
  • By year, Total Liabilities came in at $3.71 million in FY2024 (+1.2%), $3.67 million in FY2023 (-0.4%), $3.68 million in FY2022 (unchanged) and $3.68 million in FY2021 (+5.4%).
  • Five-year quarterly Total Liabilities spans a low of $3.04 million in Q2 2024 and a high of $4.09 million in Q3 2022.
  • Year over year, Total Liabilities has now increased in each of the last five quarters, with growth averaging 2.1% over the last eight quarters.
  • The high point for year-over-year Total Liabilities in five years was Q3 2022 (growth of 12.6%); the low point was Q3 2023 (a decline of 22.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.41 million (Q1 2026), $3.8 million (Q4 2025) and $3.13 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Inhibitor Therapeutics 17.38 Mn 17.38 Mn - 3.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.20 Mn
Mar 31, 2026 3.41 Mn
Dec 31, 2025 3.80 Mn
Sep 30, 2025 3.13 Mn
Jun 30, 2025 3.19 Mn
Mar 31, 2025 3.15 Mn
Dec 31, 2024 3.71 Mn
Sep 30, 2024 3.04 Mn
Jun 30, 2024 3.04 Mn
Mar 31, 2024 3.16 Mn
Dec 31, 2023 3.67 Mn
Sep 30, 2023 3.16 Mn
Jun 30, 2023 3.04 Mn
Mar 31, 2023 3.08 Mn
Dec 31, 2022 3.68 Mn
Sep 30, 2022 4.09 Mn
Jun 30, 2022 3.94 Mn
Mar 31, 2022 3.83 Mn
Dec 31, 2021 3.68 Mn
Sep 30, 2021 3.63 Mn
API Access

Inhibitor Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=INTI&period=max&api_key=YOUR_API_KEY